CLINICAL OUTCOMES OF THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PEGAPTANIB

CLINICAL OUTCOMES OF THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PEGAPTANIB

Show other versions (1)

Purpose. To evaluate the results of intravitreal use of Pegaptanib in patients with exudative age-related macular degeneration (AMD). Material end methods. Our study includes 77 patients with exudative AMD, who received 9 injections of Pegaptanib 0.3mg with 6-weeks intervals between them. So the pri...

Full description

Bibliographic Details
Main Authors:	M. Burova, J. Studnicka, N. Jiraskova, P. Rozsival, M. Kalfertova
Format:	Article
Language:	Russian
Published:	Publishing house "Ophthalmology" 2015-12-01
Series:	Офтальмохирургия
Subjects:	age-related macular degeneration choroidal neovascularization exudative pegaptanib treatment
Online Access:	https://www.ophthalmosurgery.ru/jour/article/view/149

Similar Items

Clinical outcomes of the treatment of exudative age-related macular degeneration with Pegaptanib
by: M. Burova, et al.
Published: (2013-02-01)

Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration
by: Shaikh Saad, et al.
Published: (2007-01-01)

Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
by: Umut Karaca, et al.
Published: (2012-01-01)

Pegaptanib sodium for ocular vascular disease
by: Shukla Dhananjay, et al.
Published: (2007-01-01)

Diurnal variation of optical coherence tomography–based macular fluid in exudative age-related macular degeneration
by: Blake H. Fortes, et al.
Published: (2023-09-01)

Subthreshold Exudative Choroidal Neovascularization (CNV): Presentation of This Uncommon Subtype and Other CNVs in Age-Related Macular Degeneration (AMD)
by: Vivian Paraskevi Douglas, et al.
Published: (2022-04-01)

Analysis on Conbercept for exudative age-related macular degeneration
by: Kun Li, et al.
Published: (2017-12-01)

Preliminary study of Conbercept injected intravitreally for the treatment of wet age-related macular degeneration
by: Ying Qin, et al.
Published: (2017-08-01)

Intravitreal Avastin for managing CNV due to age-related macular degeneration
by: Quan - Liang Zhao, et al.
Published: (2013-05-01)

Genetic Association between MMP9 and Choroidal Neovascularization in Age-Related Macular Degeneration
by: Elliott H. Sohn, MD, et al.
Published: (2021-03-01)

Early detection of choroidal neovascularization in age related macular degeneration
by: Tural Galbinur
Published: (2014-07-01)

Exudative versus Nonexudative Age-Related Macular Degeneration: Physiopathology and Treatment Options
by: Ana Rita Fernandes, et al.
Published: (2022-02-01)

Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration
by: Gopal Lekha, et al.
Published: (2007-01-01)

Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration
by: Hamidreza Torabi, et al.
Published: (2018-01-01)

Comparison of ranibizumab and bevacizumab in neovascular age-related macular degeneration
by: Huseyin Serdarogullari, et al.
Published: (2014-05-01)

NEW DEVELOPMENTS IN THE MANAGEMENT OF AGE-RELATED MACULAR DEGENERATION
by: Gabriele E. Lang
Published: (2004-05-01)

Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021-06-01)

Predictive models of long-term anatomic outcome in age-related macular degeneration treated with as-needed Ranibizumab
by: Lucia Gonzalez-Buendia, et al.
Published: (2017-08-01)

Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab
by: Daniel Sanju Narayan, et al.
Published: (2015-01-01)

Transpupillary thermotherapy in subfoveal choroidal neovascular membrane secondary to age-related macular degeneration
by: Verma Lalit, et al.
Published: (2004-01-01)

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01)

Role of IL-4 in bone marrow driven dysregulated angiogenesis and age-related macular degeneration
by: Takashi Baba, et al.
Published: (2020-05-01)

Intravitreal injection of Conbercept in the treatment of exudative age-related macular degeneration
by: Hong-Xia Niu, et al.
Published: (2018-09-01)

Regulation of Rac1 Activation in Choroidal Endothelial Cells: Insights into Mechanisms in Age-Related Macular Degeneration
by: Aniket Ramshekar, et al.
Published: (2021-09-01)

The Anti-Inflammatory Effect of Hydrogen Gas Inhalation and Its Influence on Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular Age-Related Macular Degeneration
by: I-Chia Liang, et al.
Published: (2021-11-01)

Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
by: Maria Cristina Savastano, et al.
Published: (2021-10-01)

Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
by: Zhe-Li Liu, et al.
Published: (2013-04-01)

Image characteristic and diagnostic value of OCTA in patients with age related macular degeneration
by: Rui-Rui Ma, et al.
Published: (2020-04-01)

THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
by: R. N. Alyautdin, et al.
Published: (2022-05-01)

Choroidal neovascularization activity and structure by optical coherence tomography angiography in age related macular degeneration
by: M. A. Kovalevskaya, et al.
Published: (2021-12-01)

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
by: Kiire CA, et al.
Published: (2015-12-01)

Age-Related Macular or Retinal Degeneration?
by: Michalina Gałuszka, et al.
Published: (2023-05-01)

Altered activation state of circulating neutrophils in patients with neovascular age-related macular degeneration
by: Marie Krogh Nielsen, et al.
Published: (2017-07-01)

Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration
by: Mohsen Farvardin, et al.
Published: (2022-10-01)

Clinical observation of intravitreal injection of Conbercept treating exudative age-related macular degeneration
by: Wei Song, et al.
Published: (2016-07-01)

Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
by: Akira Hirata, et al.
Published: (2018-03-01)

Transpupillary thermotherapy for choroidal neovascular membrane in age related macular degeneration
by: Agarwal Manisha, et al.
Published: (2004-01-01)

Neovascular Remodeling and Subretinal Fibrosis as Biomarkers for Predicting Incomplete Response to Anti-VEGF Therapy in Neovascular Age-Related Macular Degeneration
by: Jing Wu, et al.
Published: (2022-04-01)

Comparison of Ranibizumab and Pegabtanib Sodium Monotherapies in Terms of Rates of Stabilization After the First Three Doses
by: Nilüfer Koçak, et al.
Published: (2012-05-01)

Incremental economic burden associated with exudative age-related macular degeneration: a population-based study
by: Siin Kim, et al.
Published: (2019-11-01)